Newsroom

Knowledge is power in driving pharma commercialization success
Two Labs is an industry leader in all facets of pharma services. Our professional, experienced team offers a wealth of skills and knowledge to manage the complexities of pharma product commercialization, market access and market intelligence.
Two Labs Expands Services with State Drug Price Transparency Managed Service Offerings
Two Labs is officially unveiling its State Drug Price Transparency (DPT) managed service offerings to help emerging pharmaceutical manufacturers navigate the evolving regulatory landscape imposed by each state's own independent reporting requirements. Read the press release. [...]
Avoid Launch Delays By Planning For An FDA-Required REMS
REMS are FDA-mandated, post-marketing safety programs that can be required to appropriately balance a drug's benefits and risks to support safe use. These safety programs are most often required during the NDA or biologics license application (BLA) process to address [...]
Two Labs expands product launch services with the addition of Risk Evaluation & Mitigation Strategy (REMS) offerings
"We've deepened our bench of experts by adding some of the most experienced REMS professionals to our team, including Melissa Landers," said Howard Miller, CEO of Two Labs. "Melissa joins the Two Labs family as a preeminent expert in the design, [...]
Why Emerging Manufacturers Need Specialized Communications That Are Built To Scale
Emerging manufacturers have a strength in how close to and how passionate they are about the science they are developing. But because they are hyper-focused on the groundbreaking science they're working on, it can be hard to come up from the [...]
Effective Medical Communications During CGT Clinical Trials
As the cell and gene therapy market has exponentially grown in recent years — with some reports predicting it will reach $24.4 billion with 54 to 74 approvals by 2030 — many manufacturers are learning the hard way just how [...]
Achieving Launch Excellence in Oncology
It’s no surprise that putting together a successful launch strategy for an oncology product is a complex process. And we’ve heard from many of our emerging pharma clients that it’s intimidating to see how saturated and competitive the landscape [...]